Cargando…
A review and update on orphan drugs for the treatment of noninfectious uveitis
INTRODUCTION: Uveitis, a leading cause of preventable blindness around the world, is a critically underserved disease in regard to the medications approved for use. Multiple immunomodulatory therapy (IMT) drugs are appropriate for uveitis therapy but are still off-label. These IMT agents, including...
Autores principales: | You, Caiyun, Sahawneh, Haitham F, Ma, Lina, Kubaisi, Buraa, Schmidt, Alexander, Foster, C Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298311/ https://www.ncbi.nlm.nih.gov/pubmed/28203051 http://dx.doi.org/10.2147/OPTH.S121734 |
Ejemplares similares
-
Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
por: Kubaisi, Buraa, et al.
Publicado: (2018) -
Biologics for the treatment of noninfectious uveitis
por: Lin, Chang-Ping
Publicado: (2018) -
Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
por: Pasadhika, Sirichai, et al.
Publicado: (2014) -
Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013) -
Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021)